Deva Holding A.S. | Income Statement

Fiscal year is January-December. All values TRY Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
418,391.10
467,940.00
576,380.10
688,456.40
800,295.10
1,041
Cost of Goods Sold (COGS) incl. D&A
268,691.90
311,920.70
350,453.00
421,917.10
466,375.20
533
Gross Income
149,699.20
156,019.30
225,927.10
266,539.30
333,919.90
508
SG&A Expense
115,047.50
115,019.60
130,213.00
146,169.30
204,172.70
263
EBIT
33,287.20
38,962.60
94,120.70
120,370.00
129,747.30
247
Unusual Expense
191.70
838.40
11,992.90
10,724.80
470.50
-
Non Operating Income/Expense
60,220.30
6,636.60
13,866.20
11,878.40
20,064.70
14
Interest Expense
71,897.80
39,713.00
44,289.30
49,547.60
54,761.70
111
Pretax Income
24,119.20
5,047.90
51,704.70
71,976.00
94,579.70
156
Income Tax
469.50
3,653.80
4,085.80
11,644.90
2,037.10
20
Consolidated Net Income
24,588.70
8,701.70
47,619.00
60,331.10
92,542.70
136
Net Income
24,603.70
8,722.90
47,659.70
60,331.10
92,542.70
136
Net Income After Extraordinaries
24,603.70
8,722.90
47,659.70
60,331.10
92,542.70
136
Net Income Available to Common
24,603.70
8,722.90
47,659.70
60,331.10
92,542.70
136
EPS (Basic)
0.12
0.04
0.24
0.30
0.46
0.68
Basic Shares Outstanding
200,000.00
199,971.20
200,000.00
-
-
200
EPS (Diluted)
0.12
0.04
0.24
-
-
0.68
Diluted Shares Outstanding
200,000.00
199,971.20
200,000.00
-
-
200
EBITDA
57,936.00
64,160.60
120,794.20
147,839.80
160,635.20
282
Other Operating Expense
1,364.50
2,037.10
1,593.40
-
-
2
Non-Operating Interest Income
2,317.80
-
-
-
-
6
Minority Interest Expense
15.00
21.30
40.70
-
-
-

About Deva Holding

View Profile
Address
Halkali Merkez Mah. Basin Ekspres
Istanbul IB 34303
Turkey
Employees -
Website http://www.deva.com.tr
Updated 07/08/2019
Deva Holding AS engages in the research, development, and manufacture of pharmaceutical products. It operates through the following segments: Human Pharmaceuticals, Veterinary Products, and Other. The Human Pharmaceuticals segment consists of sale of branded generic and licensed products.